https://biosimilarsrr.com/2026/07/17/tracking-two-bills-to-remove-the-clinical-efficacy-study-requirement-for-biosimilar-development/ 2026-07-17T16:42:00Z Biosimilars Review & Report en Tracking Two Bills to Remove the Clinical Efficacy Study Requirement for Biosimilar Development 2026-07-17T16:40:46Z Blog https://biosimilarsrr.com/2026/07/16/another-big-3-pbm-settles-with-ftc-on-rebates-passthroughs-and-price-spreads/ 2026-07-16T14:20:25Z Biosimilars Review & Report en Another Big 3 PBM Settles With FTC on Rebates, Passthroughs, and Price Spreads 2026-07-16T14:20:23Z Blog https://biosimilarsrr.com/2026/07/15/are-two-pegfilgrastims-for-accord-biopharma-better-than-one/ 2026-07-15T15:37:39Z Biosimilars Review & Report en Are Two Pegfilgrastims for Accord BioPharma Better Than One? 2026-07-15T15:31:39Z Blog